HBM Healthcare To Sell Majority Stake In Swixx Biopharma To SK Capital Partners
(RTTNews) – HBM Healthcare Investments AG (HBMNE.SW, HBMBF), on Monday announced it has signed a binding agreement to sell a majority stake in Swixx BioPharma AG to SK Capital Partners, LP for 1.5 billion euros, while retaining a significant minority interest. The majority stake being sold in Swixx Biopharma is not quantified in the announcement. … Read more